Clinical Trials Logo

Clinical Trial Summary

SIMAP is a triple-masked randomised trial aimed at assessing whether an automated system of pictograms associated to medical indications results in better comprehension and adherence of said indications. Adult patients with a recent diagnosis of asthma will be randomised to receive a pictographic depiction of their treatments and recommended interventions or standard communication without assistance from their attending physician. Patients will be followed-up for 60 days using the Asthma Control Questionnaire (ACT). The primary endpoint of this study is the degree of asthma control as assessed by the aforementioned questionnaire. Secondary outcomes include the number of hospitalisations, emergency care unit visits and the need to increase bronchodilator therapy as per current Global Initiative for Asthma guidelines. Outcomes will be analysed under the intention-to-treat principle by a statistician unaware of treatment allocation.


Clinical Trial Description

In this triple-masked randomised trial, adult participants with a recent diagnosis of asthma (<15 days) will be allocated to receive a pictographic depiction of their medical indications or a standard description of said indications. Eligible patients will include those between 18 and 65 years of age with a diagnosis of asthma established by standard clinical recommendations (clinical and spirometric criteria as established by Global Initiative for Asthma - GINA - guidelines) and in whom therapy including a bronchodilator and a controller medication (typically an inhaled steroid) is planned to be initiated. Patients with another cause of bronchial obstruction (such as COPD), those with cognitive or visual impairments that hampers the understanding of pictograms or those with a history of alcoholism or alcohol abuse will be excluded. Patients will be randomised using a permuted block sequence which shall be kept hidden from other investigators. Participants will be followed-up at seven, thirty and sixty-day intervals using the Asthma Control Questionnaire (ACT), which is the primary outcome of this study. Participants, clinical evaluators, analysts and sponsors will be kept unaware of treatment allocation. Secondary endpoints include the inhaler technique, the correct depiction of inhaler medication purpose, the rate of emergency care visits between groups, the rate of hospitalisations between groups and the need to increase bronchodilator therapy during scheduled visits within the trial. All analyses will be conducted using the intention-to-treat principle. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05609760
Study type Interventional
Source Universidad de Concepcion
Contact Rosa L Figueroa, ScD
Phone +56 9 924956932
Email rosa.figueroa@biomedica.udec.cl
Status Recruiting
Phase N/A
Start date August 1, 2022
Completion date April 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Recruiting NCT04316715 - Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care N/A
Active, not recruiting NCT04602468 - Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) Phase 4
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Enrolling by invitation NCT04676204 - Relationship Between Oral DMT Burden and Adherence in MS
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Completed NCT05168449 - The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients N/A
Active, not recruiting NCT04612088 - Intervention for Multivitamin Adherence on Bariatric Patients N/A
Completed NCT03958331 - Behavioral Economics and Adherence in Teens (BEAT!) N/A
Completed NCT05233644 - Medication Adherence in Heart Failure After Hospitalisation
Completed NCT03837496 - Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors N/A
Recruiting NCT03683966 - MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
Withdrawn NCT04754867 - Pre-Test of For the Future Self and Smoking Cessation N/A
Recruiting NCT05996094 - Antiretroviral Adherence and Drug-level Monitoring
Not yet recruiting NCT06056037 - Making ART Work Among Brazilian Youth N/A
Completed NCT03658252 - Efficacy of Targeted Intervention for Topical Steroid Phobia. N/A
Completed NCT03651596 - Leveraging mHealth Messaging to Promote Adherence in Teens With CKD N/A
Completed NCT03842436 - Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use Phase 4
Completed NCT03081559 - Improving Engagement in HIV Care for High-risk Women N/A
Recruiting NCT05515497 - BMT4me: Post-HSCT Medication Adherence mHealth App N/A